Conditional inactivation of the TGF-beta type II receptor using Cre:Lox.
Chytil
Anna
A
Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee, USA .
Magnuson
Mark A
MA
Wright
Christopher V E
CV
Moses
Harold L
HL
D000818:Animals; D005260:Female; D017353:Gene Deletion; D020868:Gene Silencing; D019426:Integrases / Q000502:physiology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL / Q000235:genetics; D017346:Protein Serine-Threonine Kinases; D000077294:Receptor, Transforming Growth Factor-beta Type II; D018125:Receptors, Transforming Growth Factor beta / Q000235:genetics* / Q000502:physiology; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology*; D014764:Viral Proteins / Q000502:physiology
D018125:Receptors, Transforming Growth Factor beta; D014764:Viral Proteins; D017346:Protein Serine-Threonine Kinases; D000077294:Receptor, Transforming Growth Factor-beta Type II; C045073:Cre recombinase; D019426:Integrases